Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism
Patent
1988-02-23
1990-09-11
Draper, Garnette
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving viable micro-organism
435 29, 435 41, 435 4, 435 711, 435 712, 435243, 435245, 435258, 435259, 435261, 435947, 435808, 530412, 530414, 530418, 530420, 530829, C12Q 124, C12P 2100, C12N 100, C07K 312
Patent
active
049562789
ABSTRACT:
Anaplasma marginale antigen, antigen compositions, vaccine and process for the production of said antigen, antigen composition and vaccine are disclosed. The Anaplasma marginale is free of the erythrocyte antigens that cause neonatal isoerythrolysis, and effective as a vaccinate which will not only protect the vaccinate against bovine anaplasmosis, but does not induce neonatal isoerythrolysis in offspring of vaccinates.
REFERENCES:
patent: 4329331 (1982-05-01), Kallick
Palmer, Inf. and Imm., vol. 50(3) 1985, pp. 881-886.
Barbet et al, Inf. and Immunity, 1983, vol. 40, pp. 1068-1074.
Kuttler et al, Vet Microbiol., 9(2) 1984, pp. 181-186.
S. McCorkle-Shirley, MS: L. T. Hart, PhD; A. D. Larson, PhD; W. J. Todd, PhD; J. Donovan Myhand, MS, High-Yield Preparation of Purified Anaplasma Marginale from Infected Bovine Red Blood Cells; Aug. 1985, pp. 1745-1747, American Journal of Veterinary Research, vol. 46, No. 8.
D. Gene Luther; Lewis T. Hart; W. J. Todd; Ron Byford Anaplasmosis Vaccines for Cattle; Jul. 1987, pp. 4-5, The Louisiana Cattleman vol. 20, No. 7.
Susan Looney, W. J. Todd, L. T. Hart, Nell Morris, The Immune Response of the Bovine to Purified Anaplasma Marginale, Mar. 1987; p. 117, American Society for Microbiology, Abstracts of the Annual Meeting, 1987 E-84.
D. G. Luther, L. T. Hart, W. J. Todd, R. L. Byford, Bovine Anaplasmosis: Current and Future Treatments, 1985, pp. 10-11, Louisiana Agriculture, vol. 29 #1.
T. E. Amerault, A Review of the Card Test for Anaplasmosis, Mar. 19, 20, 1973, pp. 133-135, Proceedings of the Sixth National Anaplasmosis Conference.
S. Montenegro-James, M. Toro, E. Leon, B. K. Baek, A. T. Guillen, M. Ristic, Induction of Protective Immunity Against Bovine Anaplasmosis with Purified, Nonviable Anaplasma Marginale, Organisms, Nov. 29-Dec. 3, 1987, p. 78, The 36th Annual Meeting of the American Society of Tropical Medicine and Hygiene.
Guy H. Palmer, Travis C. McGuire, Immune Serum Against Anaplasma Marginale Initial Bodies Neutralizes Infectivity for Cattle; Aug. 1984, pp. 1010-1015, The Journal of Immunology, vol. 133, No. 2.
S. A. Ferenc, C. H. Courtney, M. J. Burridge, Trypanosoma Vivax in the Caribbean Basin, Nov. 29-Dec. 3, 1987, p. 78, The 36th Annual Meeting of the American Society of Tropical Medicine and Hygiene.
Hart Lewis T.
Luther Donald G.
Todd William J.
Draper Garnette
Louisiana State University
Proctor Llewellyn A.
LandOfFree
Anaplasma marginale antigen, antigen compositions, vaccine and p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anaplasma marginale antigen, antigen compositions, vaccine and p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anaplasma marginale antigen, antigen compositions, vaccine and p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1184457